INTERROS: Press Center: news

News

Press Center

phone: +7 495 785 29 07
fax: +7 499 230 32 94
press@interros.ru

Contacts

Topics

"Three Volcanoes" Park / Atomyze / buyback / Charity / Cinema Park / coronavirus / COVID-19 / DFA / donations / ecotourism / Fundamental research / Human Brain / Interport / Interros / Interros-Dostoinstvo / Konstantin Novoselov / nature tourism / Norilsk Nickel / OPIN / Petrovax Pharm / physics / Power Machines / ProfMedia / Rosa Khutor / Rosbank / Russian International Olympic University / Sochi / Soglasie / Sustainable tourism / Tagir Aushev / UNEXIM Bank / Vasta Discovery / VEB.RF / Vladimir Potanin

Calendar

prev June 2022

Mon	Tue	Wed	Thu	Fri	Sat	Sun
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

22.07.2020

International Clinical Trial Of Polyoxidonium Confirms Its Safety For Covid-19 Treatment

A Russian original medication called Polyoxidonium® by Petrovax, a pharmaceutical company affiliated to the Interros Group, has passed the first phase of an international clinical trial for its effectiveness and safety for COVID-19 treatment.

More Topics Petrovax Pharm

23.03.2020

Vladimir Potanin donates one billion rubles to support the non-profit sector in times of global instability

The Foundation is now announcing the launch of new large-scale initiatives to help non-profits and their beneficiaries to survive the next few months

More Topics COVID-19 / donations / coronavirus / Vladimir Potanin

19.04.2019

The Vladimir Potanin Foundation is Among Top-20 of the Private Russian Charities

Forbes Russia released its first ranking of Top-20 charities owned by Russian wealthiest businesspersons.